Next 10 |
2024-05-09 13:36:06 ET More on Merrimack Pharmaceuticals Merrimack Pharmaceuticals announces notification of plan to delist common stock on Nasdaq Merrimack receives $225M milestone payment from Ipsen Financial information for Merrimack Pharmaceuticals Read...
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today announced that the Board of Directors intends to declare a liquidating cash dividend in the amount of $15.10 per share, if stockholder approval of the Plan of Dissolution is obtained at...
2024-05-02 18:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
2024-04-30 17:44:17 ET More on Merrimack Pharmaceuticals Merrimack receives $225M milestone payment from Ipsen Merrimack spikes as Ipsen wins FDA label expansion for cancer therapy Financial information for Merrimack Pharmaceuticals Read the full article on...
Company Updates Potential Range of Initial Liquidating Distribution and Additional Dividend Information Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today announced that it has filed notice with NASDAQ of the Companyȁ...
2024-04-13 01:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-27 16:36:45 ET More on Merrimack Pharmaceuticals Merrimack spikes as Ipsen wins FDA label expansion for cancer therapy Financial information for Merrimack Pharmaceuticals Read the full article on Seeking Alpha For further details see: Merrimack re...
Special Meeting of Stockholders to Approve Plan of Dissolution Scheduled for Friday, May 10, 2024 at 10:00 a.m. Eastern Standard Time Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today announced that it has received a $225 mil...
Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 0.2% on the day to $14.82. Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorpora...
News, Short Squeeze, Breakout and More Instantly...
Merrimack Pharmaceuticals Inc. Company Name:
MACK Stock Symbol:
NASDAQ Market:
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today announced that the Board of Directors intends to declare a liquidating cash dividend in the amount of $15.10 per share, if stockholder approval of the Plan of Dissolution is obtained at...
2024-05-02 18:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...